CPRX - Catalyst Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5257.42M
Enterprise Value 3177.5M
Trailing P/E N/A
Forward P/E 1-22.82
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.18
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.53

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.37%
Return on Equity (ttm)-30.62%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.63M
Net Income Avi to Common (ttm)-18.41M
Diluted EPS (ttm)-0.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.01M
Total Cash Per Share (mrq)0.82
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.97
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-13.74M
Levered Free Cash Flow (ttm)-7.18M

Trading Information

Stock Price History

Beta 2.26
52-Week Change 353.61%
S&P500 52-Week Change 313.44%
52 Week High 34.51
52 Week Low 31.63
50-Day Moving Average 32.72
200-Day Moving Average 33.23

Share Statistics

Avg Vol (3 month) 3683.73k
Avg Vol (10 day) 3503.1k
Shares Outstanding 5102.56M
Float 75.89M
% Held by Insiders 113.23%
% Held by Institutions 155.38%
Shares Short 33.27M
Short Ratio 33.65
Short % of Float 34.25%
Shares Short (prior month) 33.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A